Fulgent Is Putting Its Cash Bonanza To Work
The company has raked in well over $1B of cash from its epic Covid testing ramp up, apart from a host of contacts and putting the company on the map. […]
Fulgent Genetics: Somewhat Disappoints With A Marked Slowdown In Its NGS Business
Once again, the company exceeded quarterly expectations on the flare-up of another pandemic wave. However, their core revenue, which was growing 134% last year is going to slow down to […]
3 Smallcaps That Got Flushed With The Market
Our marketplace service has largely avoided bigger growth stocks because we couldn’t justify the sky-high valuations. However, the smallcap growth stocks in which we specialize have been in a bear […]
Fulgent Shares Are Still Very Attractive
Investors worry about the demise of their insanely profitable Covid business, but they shouldn’t. The epic ramp in that business put the company on the map and will deliver $1B+ […]
Fulgent Genetics Has Another Blast Out Quarter
Fulgent produced another stellar quarter and while its Covid business will shrink, it isn’t going away anytime soon as it shifts to asymptotic and surveillance testing. Meanwhile, the company is […]
Fulgent Will Thrive After The Pandemic
Investors are buffeted through the Covid testing bonanza and the prospect of these, good for 90%+ of revenues, disappearing, with the tech selloff to boot. This explains the extreme volatility […]
Fulgent’s Epic Ramp In Testing Is One For The Ages
It’s only a relatively small player in the rapidly expanding field of genetic testing, but this is changing in front of our eyes. It was already known for the quality […]
Fulgent’s COVID-19 Tests Are Ramping Fast, But Their Other Tests Are Suffering
The company’s strong growth is likely to suffer as a result of the pandemic, but we think this is only a temporary blip. The company rapidly adjusted and developed two […]
Fulgent Genetics Is Fundamentally Sound
Fulgent’s growth is going to come down this year, according to guidance which was issued just before the coronavirus hit the US in earnest. From competitors with more recent updates, […]
Fulgent Genetics’ Impressive Growth Acceleration Has Further To Run
While it is very small relative to big competitors, it is growing much faster than the market, leading to margin expansion and operational leverage. Introducing new tests, a new consumer […]